U.S. Food Stock News

RPM International Inc. recently reported past second-quarter fiscal 2026 results, with sales rising to US$1,909.9 million while net income eased to US$161.21 million, and also completed a long-running share repurchase program totaling 12,957,724 shares for US$755.12 million. The company’s guidance for mid–single-digit sales growth in the upcoming third and fourth quarters, alongside years of buybacks, offers fresh insight into how management is balancing growth investment with returning...

Earlier this month, FuelCell Energy ended the employment of its Executive Vice President, General Counsel and Corporate Secretary Joshua Dolger without cause, and appointed Amanda J. Schreiber to those roles effective January 12, 2026. Schreiber’s extensive experience guiding complex power projects, governance, and risk management at ContourGlobal brings a power-sector-focused legal and compliance perspective to FuelCell Energy’s leadership team. Next, we’ll examine how Schreiber’s...

Latest Earnings Snapshot and How It Fits the Story Regions Financial (RF) has wrapped up FY 2025 with fourth quarter revenue of US$1,806 million and EPS of US$0.59, alongside trailing 12 month revenue of US$7.1 billion and EPS of US$2.31 that frame the full year picture. Over recent quarters the company has seen revenue move from US$1,660 million in Q1 2025 to US$1,811 million in Q3 2025, and EPS range between US$0.51 and US$0.62. This gives investors a clear line of sight on how the top line...

If you are wondering whether Automatic Data Processing's current share price reflects its underlying worth, you are not alone. Many investors are asking the same question before making their next move. The stock closed at US$260.44, with returns of a 2.1% decline over the last 7 days, a 1.9% decline over 30 days, a 3.0% gain year to date, a 10.1% decline over 1 year, 17.3% over 3 years, and 78.4% over 5 years. Taken together, these figures give a mixed picture of recent and longer term...

Regencell’s latest volatility and what is driving it Regencell Bioscience Holdings (RGC) has been in sharp focus after large price swings, linked to regulatory scrutiny of recent trading activity and warnings in its annual report about legal risks and going concern questions. See our latest analysis for Regencell Bioscience Holdings. These headlines sit on top of extremely sharp moves, with the latest share price at $27.43 after a 40.1% 7 day share price decline, even though the 30 day share...

If you are wondering whether Cloudflare's current share price lines up with its long term potential, this article will walk you through how that value stacks up using several common yardsticks. The stock last closed at US$184.17, with returns of 0.8% over 7 days, a 3.8% decline over 30 days, a 6.0% decline year to date, and a 57.2% gain over the past year. The 3 year return is very large and the 5 year return stands at 120.6%. These moves have kept Cloudflare in the spotlight as investors...

Nature's Own®, owned by Flowers Foods, recently launched Nature's Own Life™ Wheat + Protein bread, a high-protein, keto-friendly loaf with 22 grams of protein and 9 grams of fiber per serving, now available nationwide. This launch extends Flowers Foods’ better-for-you portfolio and directly targets consumers prioritizing higher protein and carb-conscious options in everyday bread. We’ll now explore how this protein-rich, keto-friendly offering may influence Flowers Foods’ investment...

Why Clear Channel Outdoor Holdings (CCO) is on some investors’ radar Clear Channel Outdoor Holdings (CCO) has caught attention after recent share price moves, with the stock showing double digit total returns over the past year and the past 3 months. See our latest analysis for Clear Channel Outdoor Holdings. Recent trading suggests momentum is building, with a 90 day share price return of 25.88% and a 1 year total shareholder return of 43.62% from a last close of $2.14. If Clear Channel...

Morgan Stanley recently named Regency Centers its top REIT pick, emphasizing the company’s grocery-anchored shopping centers in high-income, densely populated suburban markets and its outlook for funds from operations growth through 2027. The appointment of Equity Residential CEO Mark J. Parrell to Regency Centers’ board from January 2026 adds cross-sector real estate expertise that could influence future capital allocation and portfolio decisions. Now we’ll examine how Morgan Stanley’s...

National Health Investors (NHI) is back in focus after completing US$89.2 million in healthcare investments and reporting quarterly earnings per share above analyst expectations, even as revenue came in below forecasts. See our latest analysis for National Health Investors. Those Q3 earnings and the US$89.2 million of fresh healthcare investments come as the share price trades near its recent 52 week high of US$80.68. The 90 day share price return of 6.40% and 1 year total shareholder return...

In January 2026, SEALSQ Corp reported preliminary unaudited 2025 revenue of US$18,000,000, reiterated very large 2026 revenue growth guidance, and unveiled multiple quantum-security initiatives including an India-focused semiconductor joint venture and potential multi-stage investment in French quantum firm Quobly. Together with live post-quantum robotics tests and participation in high-profile policy and investor forums, these moves position SEALSQ as an increasingly influential player at...

What FIGS’ Recent Performance Tells You FIGS (FIGS) has been catching investor attention after a sharp total return over the past year, paired with annual revenue of about US$581.0m and net income of roughly US$17.6m. See our latest analysis for FIGS. At a share price of US$11.60, FIGS has seen a sharp 47.6% 90 day share price return and a 95.3% 1 year total shareholder return, suggesting momentum has picked up even after a recent 5.9% 1 day pullback. If FIGS has piqued your interest, it...

Recent share performance snapshot Without a specific news catalyst driving trading today, United Therapeutics (UTHR) still gives you a fair bit to work with based on recent price moves and the latest fundamental snapshot. The stock closed at US$464.93, with a 1 day return of about a 1.5% decline and a 7 day move of roughly a 3.8% decline. Over the past month the share price shows about a 9% decline, while the past 3 months reflect roughly a 7.3% gain. On the fundamentals side, United...

TE Connectivity (TEL) is back in focus after recent analyst commentary and investor letters highlighted its role in automotive and industrial connectivity, along with its exposure to AI related technology, prompting fresh interest in the stock. See our latest analysis for TE Connectivity. TE Connectivity’s recent 7 day share price return of about 4% and 30 day share price return above 8%, alongside a 1 year total shareholder return near 68%, suggests momentum building around its role in...

Why 10x Genomics is back on investors’ radar 10x Genomics (TXG) has attracted fresh attention after pairing a mixed 2025 revenue update with new collaborations in autoimmune disease, oncology, immuno-oncology and transplant research across several major medical institutions. See our latest analysis for 10x Genomics. The cluster of new collaborations around autoimmune disease, oncology, immuno-oncology and transplant research has arrived alongside a 30-day share price return of 30.29% and a...

Earlier this week, Eve Holding, through its subsidiary EVE UAM, LLC, entered into a syndicated credit agreement that provided a US$150,000,000 advance from a group of international banks to fund supplier payments and core production and sales activities, with repayments scheduled over four and five years at Term SOFR plus 3.10% interest. A key detail is that Eve Holding has guaranteed EVE UAM’s obligations under this facility, signaling a strong parent-level commitment to supporting the...

Why Ensign Group is on investors’ radar today Ensign Group (ENSG) is drawing attention after recent share price moves, with the stock last closing at $180.57. Investors are weighing that price against the company’s earnings profile and recent return history. See our latest analysis for Ensign Group. The recent 1 day share price decline of 1.62% to $180.57 comes after a 7 day share price return of 3.85%, while the 1 year total shareholder return of 32.22% suggests momentum has been building...

If you are wondering whether Ziff Davis is a bargain or a value trap at its current US$37.48 share price, you are not alone. The stock has returned 3.6% over the last 7 days and 4.8% over the last 30 days. Year to date it is at 10.3%, with a 31.8% decline over 1 year and a 56.1% decline over 3 years. These mixed returns sit against an ongoing stream of corporate updates and portfolio activity that continue to keep Ziff Davis on investors' watchlists. Together, these developments help explain...

If you are wondering whether Super Micro Computer's share price still lines up with its underlying value, this article will walk through what the current numbers actually suggest. The stock recently closed at US$32.64, with returns of 8.2% over 7 days, 11.1% over 30 days, 5.4% year to date, 5.9% over 1 year, and a very large 3 year and 5 year return that is more than 7x the starting point. Recent news coverage has focused on Super Micro Computer's role in high performance computing and AI...

If you are wondering whether Archer Aviation’s current share price lines up with its underlying value, you are not alone. This article is built to help you frame that question clearly. The stock recently closed at US$8.86, with returns of 0.6% over 7 days, 16.9% over 30 days, 9.0% year to date and 0.5% over 1 year, while the 3 year return sits at a very large 215.3% and the 5 year return at a 16.4% decline. Recent attention around Archer Aviation has centered on the broader electric air taxi...

If you are wondering whether ICON's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Over shorter timeframes, ICON's share price has moved only modestly, with a 0.7% return over the last week and 1.8% over the last month, while the year to date return of 3.2% decline and 1 year return of 7.8% decline contrast with a 21.1% decline over 3 years and 15.6% decline over 5 years. These returns sit...

If you are wondering whether RTX is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about future value. RTX recently closed at US$201.92, with returns of 7.1% over 7 days, 14.0% over 30 days, 7.8% year to date, 69.8% over 1 year, 129.0% over 3 years and 235.1% over 5 years. This naturally raises questions about how much optimism is already reflected in the stock. Recent headlines around RTX have focused on the company...

Citizens Financial Group previously announced that it would release its fourth quarter and full-year 2026 results on January 15, 2027, with a press release at approximately 6:20 a.m. Eastern and a conference call at 9:00 a.m., both accessible via its investor relations website. Beyond the timing update, Citizens has outlined an ambitious plan centered on substantial projected earnings growth, expanding private banking, expiring legacy interest rate hedges, and efficiency gains from AI, all...

Why CVS Health Stock Is Back in Focus After Its Latest Dividend Decision CVS Health (CVS) is drawing fresh attention after its board approved a quarterly dividend of $0.665 per share, payable on February 2, 2026, to shareholders of record on January 22. This latest dividend affirmation comes as investors weigh the company’s broad health solutions model, recent commentary around Medicare Advantage exposure, and expectations heading into the upcoming fourth quarter 2025 earnings release. See...